ContraVir Pharmaceuticals, Inc.

New Filing
CIK: 0001583771·Biotechnology·DELAWARE·Filed: Feb 14, 2014
Total Offering

$3,225,000

Amount Sold

$3,225,000

Investors

19

First Sale

Feb 4, 2014

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2013
Non-Accredited Investors
No

Related Persons

NameRole
Gary S. Jacob
Related Person
Bernard F. Denoyer
Related Person
John P. Brancaccio
Related Person
Christopher McGuigan
Related Person
Timothy Block
Related Person

Company

Hepion Pharmaceuticals, Inc.

420 Lexington Avenue

New York, NY, 10170

212-297-0020

SEC Filing

0001104659-14-010722

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free